Box score
Thrombolex, Inc.
Reported $32.8M sold in a new Form D filed March 12, 2026 (Kingston, New Jersey).
- Biggest raise
- $32.8M filed Mar 12, 2026
- League
- Bio & Health Other Health Care
- Based in
- Kingston, New Jersey
- Season rank
- #77 of 1,121 in the Bio & Health League; #680 of 10,745 overall (2026)
- Entity
- Corporation
Form D filings since 2024 3
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-03-12 | New notice | $32.8M | $51.1M | SEC |
| 2024-06-21 | New notice | $1.2M | $5M | SEC |
| 2024-05-28 | New notice | $4.8M | $4.8M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1703764.
Similar raises, 2026
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Vinci Pharmaceuticals, Inc. | Bio & Health | $20.2M |
| 2 | Grace Therapeutics, Inc. | Bio & Health | $10M |
| 3 | Ensho Therapeutics, Inc. | Bio & Health | $7.3M |
| 4 | Galenus Precision Pharmacy, Inc. rookie | Bio & Health | $5.4M |
| 5 | Linnaeus Therapeutics, Inc. | Bio & Health | $4.5M |
| 6 | Ascendia Pharmaceuticals, Inc. | Bio & Health | $4.1M |